Cyclacel Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Cyclacel Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 82.9 %, a 64.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 82.9 -150 -64.4% Sep 30, 2024
Q2 2024 97.7 -232 -70.3% Jun 30, 2024
Q1 2024 123 -298 -70.8% Mar 31, 2024
Q4 2023 172 -343 -66.6% Dec 31, 2023
Q3 2023 233 -411 -63.9% Sep 30, 2023
Q2 2023 329 -416 -55.8% Jun 30, 2023
Q1 2023 420 -482 -53.4% Mar 31, 2023
Q4 2022 516 -694 -57.4% Dec 31, 2022
Q3 2022 644 -815 -55.9% Sep 30, 2022
Q2 2022 745 -822 -52.5% Jun 30, 2022
Q1 2022 903 -745 -45.2% Mar 31, 2022
Q4 2021 1.21K -188 -13.5% Dec 31, 2021
Q3 2021 1.46K +347 +31.2% Sep 30, 2021
Q2 2021 1.57K +642 +69.4% Jun 30, 2021
Q1 2021 1.65K +946 +135% Mar 31, 2021
Q4 2020 1.4K +680 +94.6% Dec 31, 2020
Q3 2020 1.11K +470 +73.2% Sep 30, 2020
Q2 2020 925 +339 +57.9% Jun 30, 2020
Q1 2020 703 +145 +26% Mar 31, 2020
Q4 2019 719 +193 +36.7% Dec 31, 2019
Q3 2019 642 +67.4 +11.7% Sep 30, 2019
Q2 2019 586 -22.9 -3.76% Jun 30, 2019
Q1 2019 558 -0.26 -0.05% Mar 31, 2019
Q4 2018 526 +9.66 +1.87% Dec 31, 2018
Q3 2018 575 +127 +28.3% Sep 30, 2018
Q2 2018 609 +218 +55.8% Jun 30, 2018
Q1 2018 558 +178 +46.8% Mar 31, 2018
Q4 2017 516 +139 +36.8% Dec 31, 2017
Q3 2017 448 +56.6 +14.5% Sep 30, 2017
Q2 2017 391 -25.5 -6.13% Jun 30, 2017
Q1 2017 380 -70.3 -15.6% Mar 31, 2017
Q4 2016 378 -78.2 -17.2% Dec 31, 2016
Q3 2016 391 -51.6 -11.6% Sep 30, 2016
Q2 2016 416 -19 -4.38% Jun 30, 2016
Q1 2016 450 +11.4 +2.6% Mar 31, 2016
Q4 2015 456 +31.4 +7.41% Dec 31, 2015
Q3 2015 443 -4.78 -1.07% Sep 30, 2015
Q2 2015 435 -2.42 -0.55% Jun 30, 2015
Q1 2015 439 -14.8 -3.26% Mar 31, 2015
Q4 2014 424 +1.64 +0.39% Dec 31, 2014
Q3 2014 448 +103 +29.9% Sep 30, 2014
Q2 2014 438 +132 +43.3% Jun 30, 2014
Q1 2014 454 +201 +79.3% Mar 31, 2014
Q4 2013 423 +139 +48.9% Dec 31, 2013
Q3 2013 345 +5.93 +1.75% Sep 30, 2013
Q2 2013 305 -85.1 -21.8% Jun 30, 2013
Q1 2013 253 -151 -37.4% Mar 31, 2013
Q4 2012 284 Dec 31, 2012
Q3 2012 339 Sep 30, 2012
Q2 2012 390 Jun 30, 2012
Q1 2012 404 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.